Solural Pharma ApS has a total of 19 patent applications. Its first patent ever was published in 2013. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and foods and drinks are LABOMAR S R L, GIESELMANN THOMAS and NANO PHARMACEUTICAL LABORATORIES LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Mexico | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | China | 1 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | Israel | 1 | |
#11 | Japan | 1 | |
#12 | Republic of Korea | 1 | |
#13 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Food shaping | |
#3 | Therapeutic chemical compounds | |
#4 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Højgaard Bent | 10 |
#2 | Hojgaard Bent | 5 |
#3 | Bent Højgaard | 1 |
#4 | Hoejgaard Bent | 1 |
#5 | Bent Hoejgaard | 1 |
Publication | Filing date | Title |
---|---|---|
EP3157508A2 | Solid oral dosage form of lipophilic compounds | |
CA2931086A1 | Solid oral dosage form of testosterone derivative |